UB Paderborn / Katalog / Suche / in CDI

Seven-Year Follow-Up Assessment of Cardiac Function in NSABP B-31, a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel (ACP) With ACP Plus Trastuzumab As Adjuvant Therapy for Patients With Node-Positive, Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

Journal of clinical oncology, 2012-11, Vol.30 (31), p.3792-3799

2012

Link zum Volltext

Verfügbarkeit prüfen

Definitive Results of a Phase III Adjuvant Trial Comparing Three Chemotherapy Regimens in Women With Operable, Node-Positive Breast Cancer: The NSABP B-38 Trial

Journal of clinical oncology, 2013-09, Vol.31 (26), p.3197-3204

2013

Link zum Volltext

Verfügbarkeit prüfen

Oxaliplatin Combined With Weekly Bolus Fluorouracil and Leucovorin As Surgical Adjuvant Chemotherapy for Stage II and III Colon Cancer: Results From NSABP C-07

Journal of clinical oncology, 2007-06, Vol.25 (16), p.2198-2204

2007

Link zum Volltext

Verfügbarkeit prüfen

Clinical Impact of a Value-Based Decision: A Surgical Case Study

Journal of the American College of Surgeons, 2013-04, Vol.216 (4), p.800-811

2013

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Follow-Up of Cardiac Function and Quality of Life for Patients in NSABP Protocol B-31/NRG Oncology: A Randomized Trial Comparing the Safety and Efficacy of Doxorubicin and Cyclophosphamide (AC) Followed by Paclitaxel With AC Followed by Paclitaxel and Trastuzumab in Patients With Node-Positive Breast Cancer With Tumors Overexpressing Human Epidermal Growth Factor Receptor 2

Journal of clinical oncology, 2017-12, Vol.35 (35), p.3942-3948

2017

Link zum Volltext

Verfügbarkeit prüfen

Clonal dominance of CD133+ subset population as risk factor in tumor progression and disease recurrence of human cutaneous melanoma

International journal of oncology, 2012-11, Vol.41 (5), p.1570-1576

2012

Link zum Volltext

Verfügbarkeit prüfen

Diminished dose minimally invasive radioguided parathyroidectomy: a case for radioguidance

The American surgeon, 2007-07, Vol.73 (7), p.669-672

2007

Link zum Volltext

Verfügbarkeit prüfen

The risk of regional lymph node metastases in patients with melanoma less than 1.0 mm thick: recommendations for sentinel lymph node biopsy

Journal of the American College of Surgeons, 2003-09, Vol.197 (3), p.403-407

2003

Link zum Volltext

Verfügbarkeit prüfen

Sequential administration of GM-CSF (Sargramostim) and IL-2 +/- autologous vaccine as adjuvant therapy in cutaneous melanoma: an interim report of a phase II clinical trial

Cancer biotherapy & radiopharmaceuticals, 2008-06, Vol.23 (3), p.285

2008

Link zum Volltext

Verfügbarkeit prüfen

In vivo effects of sequential granulocyte-macrophage colony stimulating factor (GM-CSF) and interleukin-2 (IL-2) on circulating dendritic cells (DC) in patients with surgically resected high risk cutaneous melanoma

Journal of Clinical Immunology, 2006-07, Vol.26 (4), p.331-338

2006

Link zum Volltext

Verfügbarkeit prüfen

Perioperative adjuvant biotherapy in high-risk resected cutaneous melanoma: the results of 5 years of follow-up

Melanoma research, 2007-10, Vol.17 (5), p.310-315

2007

Link zum Volltext

Verfügbarkeit prüfen

GM-CSF and IL-2 combination as adjuvant therapy in cutaneous melanoma: early results of a phase II clinical trial

Oncology (Williston Park, N.Y.), 2005-04, Vol.19 (4 Suppl 2), p.15-18

2005

Link zum Volltext

Verfügbarkeit prüfen

Abstract 4224: CD133 knockdown sensitizes melanoma to kinase inhibitors

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.4224-4224

2015

Link zum Volltext

Verfügbarkeit prüfen

Abstract 3891: CD133 is associated with resistance of melanoma to multikinase inhibition

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.3891-3891

2014

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1097: Immunohistochemical expression of growth factor receptors in different stages of human cutaneous melanoma

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.1097-1097

2011

Link zum Volltext

Verfügbarkeit prüfen

Abstract 3349: Immunoexpression of human melanoma stem markers during progressive stages of the disease

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.3349-3349

2010

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1921: Nonadherent human melanoma cell lines from lymph node metastases coexpress B cell markers and melanoma antigens

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.1921-1921

2010

Link zum Volltext

Verfügbarkeit prüfen

Diminished dose minimally invasive radioguided parathyroidectomy : A case for radioguidance. Discussion

The American surgeon, 2007-07, Vol.73 (7), p.669-673

2007

Link zum Volltext

Verfügbarkeit prüfen

In vivo effects of sequential granulocyte-macrophage colony stimulating factor (GM-CSF) and interleukin-2 (IL-2) on depressed peripheral blood dendritic cell (DC) counts in patients with stage IIB–IV melanoma

Journal of the American College of Surgeons, 2004-09, Vol.199 (3), p.81-81

2004

Link zum Volltext

Verfügbarkeit prüfen

Prophylactic jejunostomy: A reappraisal

Surgery, 1998-10, Vol.124 (4), p.715-720

1998

Link zum Volltext

Verfügbarkeit prüfen

Divided gastric bypass: a fifteen-year experience

The American surgeon, 1998-01, Vol.64 (1), p.62

1998

Link zum Volltext

Verfügbarkeit prüfen

Granular cell tumors of the biliary tree

Surgery, 2000-07, Vol.128 (1), p.113-115

2000

Link zum Volltext

Verfügbarkeit prüfen

The Effect of Sequential Administration of Human Granulocyte-Macrophage Colony Stimulation Factor (GM-CSF) and Interleukin-2 (IL-2): A New Postoperative Adjuvant Therapy in High-Risk Melanoma Patients

Southern medical journal (Birmingham, Ala.), 2003-11, Vol.96 (Supplement), p.S30-S31

2003

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Definitive Results of a Phase III Adjuvant Trial Comparing Three Chemotherapy Regimens in Women With Operable, Node-Positive Breast Cancer: The NSABP B-38 Trial

Oxaliplatin Combined With Weekly Bolus Fluorouracil and Leucovorin As Surgical Adjuvant Chemotherapy for Stage II and III Colon Cancer: Results From NSABP C-07

Clinical Impact of a Value-Based Decision: A Surgical Case Study

Clonal dominance of CD133+ subset population as risk factor in tumor progression and disease recurrence of human cutaneous melanoma

Diminished dose minimally invasive radioguided parathyroidectomy: a case for radioguidance

The risk of regional lymph node metastases in patients with melanoma less than 1.0 mm thick: recommendations for sentinel lymph node biopsy

Sequential administration of GM-CSF (Sargramostim) and IL-2 +/- autologous vaccine as adjuvant therapy in cutaneous melanoma: an interim report of a phase II clinical trial

In vivo effects of sequential granulocyte-macrophage colony stimulating factor (GM-CSF) and interleukin-2 (IL-2) on circulating dendritic cells (DC) in patients with surgically resected high risk cutaneous melanoma

Perioperative adjuvant biotherapy in high-risk resected cutaneous melanoma: the results of 5 years of follow-up

GM-CSF and IL-2 combination as adjuvant therapy in cutaneous melanoma: early results of a phase II clinical trial

Abstract 4224: CD133 knockdown sensitizes melanoma to kinase inhibitors

Abstract 3891: CD133 is associated with resistance of melanoma to multikinase inhibition

Abstract 1097: Immunohistochemical expression of growth factor receptors in different stages of human cutaneous melanoma

Abstract 3349: Immunoexpression of human melanoma stem markers during progressive stages of the disease

Abstract 1921: Nonadherent human melanoma cell lines from lymph node metastases coexpress B cell markers and melanoma antigens

NSABP B-38: Definitive analysis of a randomized adjuvant trial comparing dose-dense (DD) AC→paclitaxel (P) plus gemcitabine (G) with DD AC→P and with docetaxel, doxorubicin, and cyclophosphamide (TAC) in women with operable, node-positive breast cancer

NSABP B-38: Definitive analysis of a randomized adjuvant trial comparing dose-dense (DD) AC followed by paclitaxel (P) plus gemcitabine (G) with DD AC followed by P and with docetaxel, doxorubicin, and cyclophosphamide (TAC) in women with operable, node-positive breast cancer

Diminished dose minimally invasive radioguided parathyroidectomy : A case for radioguidance. Discussion

In vivo effects of sequential granulocyte-macrophage colony stimulating factor (GM-CSF) and interleukin-2 (IL-2) on depressed peripheral blood dendritic cell (DC) counts in patients with stage IIB–IV melanoma

Prophylactic jejunostomy: A reappraisal

Divided gastric bypass: a fifteen-year experience

Granular cell tumors of the biliary tree

The Effect of Sequential Administration of Human Granulocyte-Macrophage Colony Stimulation Factor (GM-CSF) and Interleukin-2 (IL-2): A New Postoperative Adjuvant Therapy in High-Risk Melanoma Patients

Suchergebnisse filtern